What is the fair value of Intercure (NASDAQ-INCR) stock?

The current fair value estimate for Intercure (NASDAQ-INCR) is $1.07. This implies an estimated upside of 18.1% versus the current market price.

Is Intercure (NASDAQ-INCR) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 18.1% versus the current market price.

What is the analyst price target for NASDAQ-INCR stock?

An analyst price target for Intercure (NASDAQ-INCR) is not currently available in the latest data file.

How is the financial health of Intercure?

The current financial health read for Intercure (NASDAQ-INCR) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Intercure's next earnings date?

The next earnings date currently listed for Intercure (NASDAQ-INCR) is August 17, 2026.

Does Intercure (NASDAQ-INCR) pay dividends?

Based on the current data, dividend yield is 0.0%.

What is the P/E ratio for Intercure (NASDAQ-INCR)?

The current P/E ratio listed for Intercure (NASDAQ-INCR) is -4.3x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Intercure?

The current market capitalization listed for Intercure is 51.872 M.

What is the enterprise value of Intercure?

The current enterprise value listed for Intercure is 91.138 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Intercure?

The ticker symbol for Intercure is NASDAQ-INCR, and the stock is listed on NASDAQ.

Where is Intercure (NASDAQ-INCR) listed?

Intercure (NASDAQ-INCR) is listed on NASDAQ.

What is the debt-to-total-capital ratio for Intercure?

The current debt-to-total-capital ratio listed for Intercure is 53.7%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Intercure?

The free float listed for Intercure is 69.6%. Free float helps investors understand how much of the share base is available for public trading.

Intercure (INCR) Fair Value & Stock Analysis

Intercure (INCR)

Intercure Ltd. is a healthcare company listed on NASDAQ under the ticker INCR. Through its subsidiaries, it focuses on cannabis-related pharmaceutical activities, including research, cultivation, production, marketing, and distribution of medical-use cannabis products in Israel and other markets. Its product range includes dried cannabis flower and cannabis extract formulated with oil. The company also maintains investments in the biomed sector. Intercure has a strategic alliance with Cannasoul R&D Ltd. aimed at developing and commercializing cannabis-based therapeutics supported by research evidence. Incorporated in 1994, the company is headquartered in Herzliya, Israel.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Upcoming Dividend Ex-Date	Dividend Payment Date	Upcoming Dividend	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NASDAQ-INCR	$1.07	18.1% Upside	Undervalued	—	—	—	Fair	—	—	—	0.0%	August 17, 2026	-4.3x	0.4x	0.6x	51.872 M	91.138 M	53.7%	69.6%	3.0	—	-37.2%

Send a message